en

PRODUCT DETAIL

CARLEVO 25 mg/100 mg

Code 3818E
MA number 27/0152/23-S
Product Form: tbl 100x25 mg/100 mg (fľ.HDPE)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 27 - ANTIPARKINSONICA
ATC:
N NERVOUS SYSTEM
N04 ANTI-PARKINSON DRUGS
N04B DOPAMINERGIC AGENTS
N04BA Dopa and dopa derivatives
N04BA02 Levodopa and decarboxylase inhibitor
Shelf life: 24
Container: bottle HDPE
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 26.06.2023
Validity: 26.06.2028
PIL: PIL_CARLEVO 25 mg_100 mg_10.2023.pdf  
SPC: SPC_CARLEVO 25 mg_100 mg_10.2023.pdf  
Safety feature Yes
Data update: 26.10.2023
eu-flag.png sk-flag.png